DBT/NER/95/SP39801/2020
Various studies have demonstrated that patients suffering from diabetes, severe obesity, hypertension and cardiovascular disease are more prone to experiencing unfavorable outcomes following infection with COVID-19 (84)
Developing new drugs involves years of clinical trials, regulatory approvals, and continuous innovation to ensure safety and efficacy
The SURPASS Phase 3 global clinical development project has enrolled more than 13,000 type 2 diabetes patients in 10 clinical trials, 5 of which are global registration studies
You pay full price until meeting your deductible, then coinsurance kicks in: This is significantly more expensive but still far below the $16,200 full cash price
Although referenced studies may historically involve in vivo data, this content and the DSIP product are presented exclusively for in vitro laboratory use only